8 results match your criteria: "New York Presbyterian Children's Hospital[Affiliation]"
J Pediatr
January 2025
Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA.
J Pediatr
February 2021
Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA. Electronic address:
Objective: To evaluate the associations between the primary indication for extracorporeal membrane oxygenation (ECMO) in neonates and neurodevelopmental outcomes at 12 and 24 months of age.
Study Design: This is a retrospective cohort study of neonates treated with ECMO between January 2006 and January 2016 in the Children's Hospital of Philadelphia newborn/infant intensive care unit. Primary indication for ECMO was classified as medical (eg, meconium aspiration syndrome) or surgical (eg, congenital diaphragmatic hernia).
J Pediatr Intensive Care
June 2020
Department of Pediatrics, Columbia University Medical Center, New York-Presbyterian Children's Hospital, New York, United States.
J Pediatr
August 2019
Computational Health Informatics Program, Harvard Medical School & Boston Children's Hospital, Boston, MA.
Objective: To investigate racial and ethnic differences in pulmonary hypertension subtypes and survival differences in a pediatric population.
Study Design: This was a retrospective analysis of a cohort of patients with pulmonary hypertension (aged ≤18 years) enrolled in the Pediatric Pulmonary Hypertension Network registry between 2014 and 2018, comprising patients at eight Pediatric Centers throughout North America (n = 1417).
Results: Among children diagnosed after the neonatal period, pulmonary arterial hypertension was more prevalent among Asians (OR, 1.
Pediatr Blood Cancer
June 2017
Children's Hospital Colorado, University of Colorado, School of Medicine, Aurora, Colorado.
Nephron Exp Nephrol
March 2006
Department of Urology, Institute for Pediatric Urology, New York Presbyterian Children's Hospital, New York, NY, USA.
Background/aims: Both TGF-beta and cyclooxygenase-2 have been implicated in the pathogenesis of interstitial fibrosis in unilateral ureteral obstruction (UUO). Cyclic tensile stretch has been used in vitro to mimic the changes in intrarenal pressure in UUO. We sought to determine the effect of meloxicam (a selective cyclooxygenase-2 inhibitor) on extracellular matrix and TGF-beta synthesis in stretched renal fibroblasts (NRK-49F).
View Article and Find Full Text PDFJ Urol
February 2004
Department of Urology, New York Presbyterian Children's Hospital, New York, USA.
Purpose: Unilateral ureteral obstruction (UUO) results in a significant change in renal blood flow (RBF) and glomerular filtration rate (GFR) by 24 hours. The intake of L-arginine, a substrate of nitric oxide (NO) synthase (NOS), can augment NO production. NO can maintain renal function through its vasodilatory action.
View Article and Find Full Text PDFAm J Physiol Renal Physiol
March 2004
Department of Urology, New York Presbyterian Children's Hospital-Weill Cornell Medical School, New York, NY 10021, USA.
Interactions between transforming growth factor-beta (TGF-beta) and nitric oxide (NO) are important in the pathophysiology of unilateral ureteral obstruction (UUO). Dopamine (DA) is a vasoactive renal mediator active at the D(1A) receptor (D(1A)R), which has not been studied in UUO; therefore, we examined the interactions among DA, TGF-beta, and NO in UUO. In vivo, UUO was carried out in rats with or without concurrent treatment with 1D11, a monoclonal antibody to TGF-beta, for 14 days.
View Article and Find Full Text PDF